Status:
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study will evaluate the efficacy and safety of a first-line regimen of Avastin and Xelox (Xeloda + Eloxatin) followed by Avastin and Tarceva, in patients with metastatic colorectal cancer. Patien...
Eligibility Criteria
Inclusion
- adult patients, \>=18 years of age;
- adenocarcinoma of colon or rectum, with metastatic disease;
- \>=1 measurable lesion.
Exclusion
- previous treatment with Avastin or Tarceva;
- previous systemic treatment for advanced or metastatic disease;
- adjuvant treatment for non-metastatic disease in past 6 months.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01135498
Start Date
November 1 2006
End Date
April 1 2010
Last Update
February 6 2015
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Palma de Mallorca, Balearic Islands, Spain, 07198
2
Sabadell, Barcelona, Barcelona, Spain, 08208
3
Terrassa, Barcelona, Spain, 08221
4
Burgos, Burgos, Spain, 09006